David Bagga
JUNE 19, 2023
A medical sales rep is the person who forms a liaison between medical companies and healthcare professionals who use their products. The sales rep is the main point of contact between the two. Medical Device Sales Career Home Blog What Does a Medical Sales Rep Do? What does a Medical Sales Rep do? A medical […] The post What does a medical sales rep do?
MedCity News
JUNE 19, 2023
One health system that initiated a journey mapping process for breast health services focused on connecting patients with a breast surgeon within 48 hours. But for the patient, that’s not 48 hours. That’s 10,000 moments of terror, she told them. Understanding this, the health system redesigned how it communicated with patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 19, 2023
UK-based pharmaceutical giant GSK has announced that the US Food and Drug Administration (FDA) has extended the review period of its new drug application (NDA) for the rare bone cancer drug momelotinib by three months. The FDA will make an approval decision by the new Prescription Drug User Fee Act (PDUFA) target action date of 16 September 2023. The reason for this review extension was undisclosed in the announcement.
MedCity News
JUNE 19, 2023
As the industry focuses on creating a more holistic, inclusive experience, these three focus areas can help bridge the gap between patient, site, and clinical research administrators and help to modernize the clinical trial experience for all.
Pharmaceutical Technology
JUNE 19, 2023
Indian pharmaceutical company Laurus Labs has signed a memorandum of agreement (MoA) with the Indian Institute of Technology, Kanpur (IIT Kanpur) to bring new gene therapy products to the market. The pharma company will in-license a small number of gene therapy products and offer research grants to advance them through pre-clinical development. Laurus Labs will be responsible for launching these products in India and emerging markets.
European Pharmaceutical Review
JUNE 19, 2023
A novel oral ‘robotic pill’ demonstrated a high success rate of drug delivery , according to clinical trial data presented at the Endocrine Society ’s annual meeting (ENDO 2023). “We believe this study provides the first clinical evidence of safe and successful delivery of the osteoporosis drug teriparatide through an oral robotic pill,” stated Arvinder Dhalla, Vice President of Clinical Development at Rani Therapeutics, which was the company that developed the technology.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Medgadget
JUNE 19, 2023
Researchers at Rockefeller University have developed a cell culture platform in which to grow ‘lung buds’ from human embryonic stem cells. The tiny structures are similar to the lung buds that form during fetal development, and they contain tiny airways and alveoli. The researchers create the structures in a bio-reactor style device that is furnished with microfluidic chips in which the lung buds grow.
MedCity News
JUNE 19, 2023
Health insurers can support the fight for reproductive health rights by improving their benefits and using their power to enact change with lawmakers, said Alexis McGill Johnson, president and CEO of Planned Parenthood Federation of America and the Planned Parenthood Action Fund. She made these comments at the AHIP 2023 conference in Portland.
Medgadget
JUNE 19, 2023
Researchers at the University of Pennsylvania have developed nanorobots that can travel to the site of a fungal infection under the influence of an external magnetic field, bind to the fungal cells, and then release reactive oxygen species to completely destroy the fungus. The tiny particles are an example of catalytic nanoparticles, which the researchers have dubbed ‘nanozymes’.
MedCity News
JUNE 19, 2023
Massachusetts Institute of Technology Bioengineering Professor Ram Sasisekharan and his lab have been cleared of research misconduct allegations following a lengthy university investigation.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
PharmaTimes
JUNE 19, 2023
Partnership will help NHS to prepare for fundamental change, including reducing carbon emissions - News - PharmaTimes
MedReps
JUNE 19, 2023
You jumped through all of the hoops to get a new medical sales job. You completed all of the interviews, spoke with numerous people at the company and even prepared a short sales pitch to show off your skills. However, for whatever reason, you can’t take the job you just accepted. What do you do now? How do you turn down the job without hurting anyone’s feelings or ruining your reputation?
PharmaTimes
JUNE 19, 2023
Vital financing will be used to develop novel therapies for condition with high unmet medical need - News - PharmaTimes
European Pharmaceutical Review
JUNE 19, 2023
A paper published in Scientific Reports has highlighted an effective method for rapid pathogenic fungal identification. While the study of microbiota has been revolutionised by DNA metabarcoding, molecular phylogenetic analysis of fungi is still a challenge, according to the authors. The lack of standardised tools and the incompleteness of reference databases limits the accurate and precise identification of fungal taxa.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Copyright Clearance Center
JUNE 19, 2023
The post Advice for Publishers on AI appeared first on Copyright Clearance Center.
Spotio
JUNE 19, 2023
ADDISON, TEXAS JUNE 20, 2023 – SPOTIO, a leading field sales engagement software provider, has been recognized with a record-setting twenty G2 awards in the field sales space for Summer 2023. Most notably, the platform has been awarded badges for the best results, usability, best ROI, highest user adoption, and most implementable. This achievement, coupled with their continued ranking as the top provider in the space, is a testament to SPOTIO’s commitment to empowering field sales te
Pharmaceutical Technology
JUNE 19, 2023
Although only a small number of gene therapies have reached the market thus far, the industry is poised to grow quickly over the next few years. Pharmaceutical companies are putting their trust in the immense potential this new generation of medicine has for treating individuals with rare genetic diseases, which currently affect an estimated 280 million patients worldwide.
Legacy MEDSearch
JUNE 19, 2023
The US Food and Drug Administration has approved the use of iTFlow® in blood flow analysis. The FDA approval is significant as it recognizes the safety and effectiveness of iTFlow® in analyzing blood flow through 4D Flow MRI data, with the potential to enhance diagnostic accuracy for patients with cardiovascular diseases and heart conditions. The FDA approval of iTFlow® will enable healthcare professionals to make more precise and effective decisions in patient care. iTFlow® is an innovative sof
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Pharmaceutical Technology
JUNE 19, 2023
The Chinese patent authority has granted approval for Medivir’s patent application for fostroxacitabine bralpamide (Fostrox). The patent covers substance claims for Fostrox as well as its use to treat liver cancer. It will remain valid until 2035 and is expected to be extended up to five years after that in important markets. The company already holds patents for Fostrox in the EU, Japan, the US and a number of other countries, mainly in Asia.
Pharma Leaders
JUNE 19, 2023
Rosemont Pharmaceuticals has acquired Lucis Pharma, which is a specialist pharmaceutical business in the UK, for undisclosed amount. With the acquisition , Rosemont will expand its existing portfolio and gain access to the new pipeline of products, providing lifesaving pharmaceuticals across the UK and within overseas markets. The acquisition will also allow Rosemont to widen its portfolio and foray into the unit dose or sachet market via the pipeline products and expand its business via recent
Contrarian Sales Techniques
JUNE 19, 2023
Embracing Change: It's Okay to Seek a New Path So, you're thinking about getting out of pharmaceutical sales. Guess what? It's perfectly fine. Careers, much like life, are not always linear. They're more like a winding road with a multitude of paths to explore. Moving away from a certain job doesn't mean failure; it just means you're ready for a new challenge.
Pharmaceutical Technology
JUNE 19, 2023
Coherus BioSciences has signed a definitive merger agreement to buy clinical-stage immuno-oncology (I-O) company Surface Oncology, in a deal valued at $65m. The company will buy all outstanding Surface Oncology shares at a price of $5.2831 per share, totalling approximately $40m, along with anticipated net cash of between $20 and $25m. Coherus BioSciences will gain access to Surface Oncology’s two differentiated clinical stage assets, SRF388 and SFR114.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Contrarian Sales Techniques
JUNE 19, 2023
Discovering the World of Part-Time Pharma Sales If you're looking to dip your toes into the healthcare industry without committing to a full-time role, part-time pharma sales jobs might just be your golden ticket. It's like tasting a slice of the pharmaceutical sales world without having to buy the whole cake. Plus, it's a great way to maintain work-life balance while still reaping the benefits of a rewarding career.
Pharmaceutical Technology
JUNE 19, 2023
Bio-Thera Solutions and Biomm have entered a licensing and supply agreement for Bio-Thera’s BAT2206, a ustekinumab biosimilar. Biomm will gain exclusive rights for the distribution and marketing in Brazil of the proposed biosimilar to Janssen’s Stelara. Bio-Thera will handle BAT2206’s global development and commercial supply out of its manufacturing plants in Guangzhou, China.
Contrarian Sales Techniques
JUNE 19, 2023
What's in a Role: The Life of a Pharmacy Rep Ever wondered what it's like to be a pharmacy rep ? It's not all about pushing sales or persuading pharmacists. It's a role that mixes knowledge, people skills, and a whole lot of enthusiasm. As a pharmacy rep, you're the face of the pharmaceutical company, bridging the gap between manufacturers and pharmacists.
PharmaTech
JUNE 19, 2023
Process equipment used in the healthcare and pharmaceutical industries follow rigid specifications for accuracy, consistency and cleanliness.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Pharmacy Times
JUNE 19, 2023
Liam Volk, MPharm, president-elect of the Pharmacists’ Defence Association LGBT+ Network, discussed how pharmacists can best support their LGBTQ+ colleagues and patients.
Sales Pilot Medical Sales Performance
JUNE 19, 2023
Is there a medical sales success secret? When seeking advice on excelling in medical sales, the usual response is to work hard, put in long hours, outshine your competitors, and always be accessible to clients. However, a critical aspect of success often goes unmentioned: learning how to detach from work. While this may sound simple, it can be challenging to put into practice.
Pharmacy Times
JUNE 19, 2023
Trial results demonstrated that 58.5% of individuals receiving luspatercept-aamt (Reblozyl; Bristol Myers Squibb) achieved the primary endpoint of red blood cell transfusion independence of at least 12 weeks.
PharmExec
JUNE 19, 2023
Research to focus on the treatment of atherosclerotic cardiovascular disease.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
130 
Let's personalize your content